Fibrous stroma: Driver and passenger in cancer development

V Sharma, J Letson, S Furuta - Science signaling, 2022 - science.org
Cumulative evidence shows that fibrogenic stroma and stiff extracellular matrix (ECM) not
only result from tumor growth but also play pivotal roles in cellular transformation and tumor …

Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis

AF Irvine, S Waise, EW Green, B Stuart, GJ Thomas - Scientific reports, 2021 - nature.com
Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment
with evidence suggesting they represent a heterogeneous population. This study …

Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis

NI Enukashvily, NV Ponomartsev, A Ketkar… - Cell death & …, 2023 - nature.com
The abnormal tumor microenvironment (TME) often dictates the therapeutic response of
cancer to chemo-and immuno-therapy. Aberrant expression of pericentromeric satellite …

Remodeling of stromal cells and immune landscape in microenvironment during tumor progression

L Arora, D Pal - Frontiers in Oncology, 2021 - frontiersin.org
The molecular understanding of carcinogenesis and tumor progression rests in intra and
inter-tumoral heterogeneity. Solid tumors confined with vast diversity of genetic …

The biological and biomechanical role of transglutaminase-2 in the tumour microenvironment

R Tempest, S Guarnerio, R Maani, J Cooper, N Peake - Cancers, 2021 - mdpi.com
Simple Summary Transglutaminase-2 (TG2) is an enzyme primarily involved in protein cross-
linking, which has been shown to play a role in the development and progression of …

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting

CJ Hanley, GJ Thomas - British journal of cancer, 2020 - nature.com
Recent studies have highlighted a major role for cancer-associated fibroblasts (CAFs) in
promoting immunotherapy resistance by excluding T cells from tumours. Recently, we …

The ferroxidase hephaestin in lung cancer: pathological significance and prognostic value

P Zacchi, B Belmonte, A Mangogna, G Morello… - Frontiers in …, 2021 - frontiersin.org
Hephaestin (HEPH) belongs to a group of exocytoplasmic ferroxidases which contribute to
cellular iron homeostasis by favouring its export. Down-regulation of HEPH expression …

Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade

C Zheng, Y Xiao, C Chen, J Zhu, R Yang… - Briefings in …, 2021 - academic.oup.com
Targeting tumor microenvironment (TME), such as immune checkpoint blockade (ICB), has
achieved increased overall response rates in many advanced cancers, such as non-small …